ATC	Anaplastic Thyroid Cancer
AKT	V-Akt Murine Thymoma Viral Oncogene Homolog
AKTi	V-Akt Murine Thymoma Viral Oncogene Homolog inihibitors
ALK	Anaplastic Lymphoma Kinase
DDR1	Discoidin Domain Receptor Tyrosine Kinase 1
DTC	Differentiated Thyroid Cancer
FAK	Focal Adhesion Kinase
FAKi	Focal Adhesion Kinase inhibitors
FTC	Follicular Thyroid Cancer
EGFR	Epidermal Growth Factor Receptor
ERK	Extracellular Signal-Regulated Kinase
IGF-1	Insulin-like growth ligand 1
IGF-2	Insulin-like growth ligand 2
IGF-IR	Insulin-like growth factor receptor I
IGF-IIR	Insulin-like growth factor receptor II
IGFBP	Insulin-like growth factor binding protein
IRA	Insulin receptor isoform A
IRB	Insulin receptor isoform B
IRS	Insulin receptor substrate
IGF-	Insulin-like growth factor receptor monoclonal antibodies
IRmAbs	Insulin-like growth factor receptor tyrosine kinase inhibitors
IGF-IRTKIs	Mitogen-Activated Protein Kinase
MEK	Mammalian Target of Rapamycin inhibitors
MEKi	Mitogen-Activated Protein Kinase inhibitors
MET	MET Proto-Oncogene, Receptor Tyrosine Kinase
mTOR	Mammalian Target of Rapamycin
MTC	Neural Precursor Cell Expressed, Developmentally Down-Regulated 4
NEDD4	Sodium Iodide Symporter
NIS	Platelet Derived Growth Factor Receptor
PDGFR	Poorly Differentiated Thyroid Cancer
PDTC	Phosphatidylinositol kinase
PI3K	Phosphatidylinositol kinase inhibitors
PI3Ki	Papillary Thyroid Cancer
PTC	Proto-Oncogene Serine/Threonine-Protein Kinase
RECIST	Response Evaluation Criteria in Solid Tumors
RTK	Receptor tyrosine kinase
SHC	Src Homology 2 Domain Containing) Transforming Protein 1
TSH	Thyroid Stimulating Hormone
TKI	Tyrosine Kinase Inhibitors
VEGF	Vascular Endothelial Growth Factor
VEGFR	Vascular Endothelial Growth Factor Receptor